Joel Greenblatt

Joel Greenblatt

Last Update: 05-15-2017

Number of Stocks: 975
Number of New Stocks: 268

Total Value: $7,876 Mil
Q/Q Turnover: 33%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Joel Greenblatt Watch

  • 5 High-Yield Dividend Stocks to Own

    A high dividend is anything over 5%, especially in companies that in 20 years could be paying out much more of the earnings to shareholders. Interestingly enough, three of the vehicles are attached to private equity firms, an industry historically inaccessible to the average (even noninstitutional) investor. Here are five stocks that provide both income and long-term growth potential.


    Carlyle Group (NASDAQ:CG)
      



  • 7 Companies With Growing Revenue and Earnings

    The following companies have boosted their revenue and earnings over the last three years.


    AerCap Holdings NV (NYSE:AER) has a five-year revenue growth rate of 37% and a five-year earnings per share (EPS) growth rate of 39%. The stock is trading with a price-earnings (P/E) ratio of 7.8 and has a six-month return of 8.1%.

      


  • What's Going On With This $11 Billion Tech Leader?

    The future of Xerox (NYSE:XRX) is somewhat fragile due to intense competition from mobile devices that serve as an alternative to print. In order to face the future, Xerox needs to expand its offering in managed print services; otherwise the future growth of the company will be compromised.


    Several phenomena like digitalization of documents, single printing devices (smartphones and tablets) and lower volumes of printers in offices are behind the company's principal risks. Xerox’s separation of its business (printing equipment and services operations) and the cost-cutting plans will impact positively by 2019.

      


  • What's Behind the Harley-Davidson Reductions?

    Things are not going well for Harley-Davidson Inc. (NYSE:HOG) as it has seen a slowdown in activity in the first half of the year. The second half should see an increase in shipments to offset the 10% decline in the first period.


    Moreover, the company needs to make more of an effort in reaching higher prices for its new models or lower costs to expand operating margins. With more than 100 years of manufacturing experience, Harley-Davidson has built a prestigious brand and consolidated customer loyalty.

      


  • Lou Simpson Sells Wells Fargo, Berkshire, Ametek

    Lou Simpson (Trades, Portfolio) is manager of SQ Advisors. He manages a portfolio composed of 14 stocks with a total value of $2.619 billion. During the first quarter the guru sold shares in the following stocks:


    The AMETEK Inc. (AME) position was reduced by 31.55% with an impact of -3.28% on the portfolio.

      


  • A Look at Joel Greenblatt’s Investment in Kroger

    Joel Greenblatt (Trades, Portfolio) initiated a position in Kroger (NYSE:KR) last quarter, buying 1,287,571 shares for an average price of $31.95 per share.


    Greenblatt tries to find cheap and good companies. He looks for value with a catalyst. Greenblatt likes special situations and thinks they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principles in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what "normalized earnings" will be three to four years in the future. Greenblatt makes sure the stock is cheap based on normalized earnings.

      


  • 9 Stocks Joel Greenblatt Continues to Buy

    Joel Greenblatt (Trades, Portfolio) is founder and managing partner of Gotham Asset Management LLC . In both first-quarter 2017 and fourth-quarter 2016 the guru bought shares in the following stocks:


    Quantum Corp. (QTM)

      


  • 3 Magic Formula Stocks Ready to Move Up

    Do what everyone else does and you will just get the same results.


    But does the Magic Formula really work?

      


  • Biotech Has a Promising Future

    Aptevo Therapeutics (NASDAQ:APVO), a spinoff from Emergent BioSolutions (NYSE:EBS), focuses on novel oncology (cancer) and hematology (blood disease).


    Aptevo currently has four main revenue-generating products. In 2016, although the commercial portfolio revenue jumped by 30% year over year, its loss doubled to $126 million. The sudden rise in operation loss was due to $71 million impairment. I considered this a conservative accounting approach that Aptevo takes.

      


  • Risk-Reward With Urban Outfitters

    The entire retail industry has been beaten down of late, especially Urban Outfitters Inc. (NASDAQ:URBN), which has been cut in half since November. Now trading near a 52-week low with a market cap of $2.2 billion, the question is whether or not the company will survive long term.


    The answer is yes

      


  • Kinross Gold to Forge Alliance With White Gold, Agnico Eagle Mines

    Kinross Gold Corp. (NYSE:KGC) has agreed to purchase an interest stake of approximately 19.9% in White Gold Corp. (TSXV:WGO). Closing dependent on the satisfaction of customary conditions and the approval of TSX Venture Exchange is expected sometime during this quarter.


    The company says that the completion of the transaction is also conditional to the “concurrent closing of a private placement to Agnico Eagle (NYSE:AEM) to maintain its proportionate interest in White Gold” since Agnico Eagle Mines also has a 19.9% interest stake in the Canadian explorer.

      


  • Cisco Systems: A Better Bargain Than Ever?

    (Published by Nicholas McCullum on May 19)


    Cisco Systems Inc. (NASDAQ:CSCO) recently reported financial results for the third quarter of fiscal 2017.

      


  • AbbVie's Humira Loses Patent in Coherus’ Petitions

    It seems that the decision of the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board to rule “in favor of Coherus’ petitions for Inter Partes Review (“IPR”) of AbbVie’s U.S. Patent 8,889,135 (the 135 Patent)” as reported by Coherus Biosciences (NASDAQ:CHRS) through its Web site, is not weighing so much on AbbVie Inc. (NYSE:ABBV) whose shares have – in contrast – resumed their uptrending and are $65.40 each, up 3 cents or plus 6% from the previous trading day.


    The decision of the Patent Trial and Appeal Board, reports Coherus Biosciences, to invalidate “all claims of the patent that were directed to a method for treating rheumatoid arthritis by administering 40 mg of HUMIRA® subcutaneously every 13 to 15 days,” opens the door to the launch on the market of Coherus Biosciences’ CHS-1420 as a biosimilar of Humira, the trade name under which AbbVie markets adalimumab, a drug used to treat patients affected with rheumatoid arthritis.

      


  • General Electric CEO Invests in Company

    General Electric Co. (GE) Chairman and CEO Jeffrey Immelt (Insider Trades) purchased 100,000 shares for $28.07 per share on May 15. The total transaction was $2,807,000.


    General Electric, a global digital industrial company encompassing a wide range of products from energy-saving technology to digital services, has a market cap of $243.498 billion.

      


  • Joel Greenblatt’s Top 3 New Stocks for the 1st Quarter

    Gotham Asset Management’s Joel Greenblatt (Trades, Portfolio) gained 268 new holdings in the first quarter. His top three new positions are The Kroger Co. (NYSE:KR), VF Corp. (NYSE:VFC) and Ancher Daniels Midland Co. (NYSE:ADM).


    Known for creating Magic Formula investing, Greenblatt invests in companies with high returns on capital and earnings yield. The firm invests in companies trading at the biggest discount to their value. The current portfolio is composed of 975 stocks and is valued at $7.8 billion.

      


  • 7 Rising Stocks That Beat the Market

    According to GuruFocus' All-in-One Guru Screener, the following are some of the stocks that have outperformed the Standard & Poor's 500 Index over the last 12 months and were bought by gurus during the last quarter.


    Arista Networks Inc. (ANET) with a market cap of $10.05 billion has outperformed the S&P 500 Index by 97.2% in the last year.

      


  • Rising Revenue and Earnings

    The following companies have boosted their revenues over the last three years as well as their earnings. This figure can be a good starting point for a profitable investment.


    InterDigital Inc. (IDCC) has a five-year revenue growth rate of 15% and a five-year earnings per share (EPS) growth rate of 21%. The stock is trading with a price-earnings (P/E) ratio of 9.5, and the price has a positive return of 15% over the last six months.

      


  • A Superior Option in Energy Services

    Superior Energy Services (NYSE:SPN) serves major, national and independent oil and natural gas exploration and production companies around the world.


    Over the last five years, the company has been in a slump.

      


  • Winnebago Is a Good Buy

    Winnebago Industries Inc. (NYSE:WGO) sells recreational vehicles to a network of 450 dealers in the United States and Canada. The stock popped up on a recent screen because its price-earnings multiple dropped below 15 and it pays out more than 1% as dividends.


    To my surprise, Winnebago has generated over a billion dollars in sales in the last 12 months, pushing $55 million to the bottom line. In fact, since 2009, sales are up over 400% and the company has turned its profit and growth prospects around significantly.

      


  • Joel Greenblatt Talk at Google

    Guru Joel Greenblatt (Trades, Portfolio) is kind of unique in the sense that he understands quantitative investing really well but still believes doing old-school analysis adds value to that process. He's a perfect guest for a Google Talk on investing and I was delighted to see he made an appearence there.


      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}